[1]
|
Boguszewski CL, Paz-Filho G, Velloso LA. Neuroendocrine body weight regulation:integration between fat tissue, gastrointestinal tract, and the brain[J]. Endokrynol Pol, 2010, 61(2):194-206. |
[2]
|
Morton GJ, Cummings DE, Baskin DG, et al. Central nervous system control of food intake and body weight[J]. Nature, 2006, 443(7109):289-295. |
[3]
|
Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat[J]. Proc R Soc Lond B Biol Sci, 1953, 140(901):578-596. |
[4]
|
Schwartz MW, Woods SC, Porte D, Jr., et al. Central nervous system control of food intake[J]. Nature, 2000, 404(6778):661-671. |
[5]
|
Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats[J]. J Comp Physiol Psychol, 1973, 84(3):488-495. |
[6]
|
Cowley MA,Smart JL,Rubinstein M,et al.Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus[J].Nature,2001,411(6836):480-484. |
[7]
|
Horvath TL. The hardship of obesity:a soft-wired hypothalamus[J]. Nat Neurosci, 2005, 8(5):561-565. |
[8]
|
Myers MG, Jr., Munzberg H, Leinninger GM, et al. The geometry of leptin action in the brain:more complicated than a simple ARC[J]. Cell Metab, 2009, 9(2):117-123. |
[9]
|
Grill HJ. Distributed neural control of energy balance:contributions from hindbrain and hypothalamus[J]. Obesity (Silver Spring), 2006, 14 Suppl 5:216S-221S. |
[10]
|
Grill HJ. Leptin and the systems neuroscience of meal size control[J]. Front Neuroendocrinol, 2010, 31(1):61-78. |
[11]
|
Ravinet Trillou C, Delgorge C, Menet C, et al. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity[J]. Int J Obes Relat Metab Disord, 2004, 28(4):640-648. |
[12]
|
Farooqi S, O'Rahilly S. Genetics of obesity in humans[J]. Endocr Rev, 2006, 27(7):710-718. |
[13]
|
Niswender KD, Morrison CD, Clegg DJ, et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus:a key mediator of insulin-induced anorexia[J]. Diabetes, 2003, 52(2):227-231. |
[14]
|
Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways:insights into insulin action[J]. Nat Rev Mol Cell Biol, 2006, 7(2):85-96. |
[15]
|
Ahima RS, Lazar MA. Adipokines and the peripheral and neural control of energy balance[J]. Mol Endocrinol, 2008, 22(5):1023-1031. |
[16]
|
Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes[J]. Trends Endocrinol Metab, 2000, 11(6):212-217. |
[17]
|
Wallenius K, Jansson JO, Wallenius V. The therapeutic potential of interleukin-6 in treating obesity[J]. Expert Opin Biol Ther, 2003, 3(7):1061-1070. |
[18]
|
Cummings DE, Overduin J. Gastrointestinal regulation of food intake[J]. J Clin Invest, 2007, 117(1):13-23. |
[19]
|
Drucker DJ. The biology of incretin hormones[J]. Cell Metab, 2006, 3(3):153-165. |
[20]
|
Wynne K, Park AJ, Small CJ, et al. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects:a double-blind, randomized, controlled trial[J]. Diabetes, 2005, 54(8):2390-2395. |
[21]
|
Degen L, Oesch S, Casanova M, et al. Effect of peptide YY3-36 on food intake in humans[J]. Gastroenterology, 2005, 129(5):1430-1436. |
[22]
|
Kovacs EM, Lejeune MP, Westerterp-Plantenga MS. The effects of enterostatin intake on food intake and energy expenditure[J]. Br J Nutr, 2003, 90(1):207-214. |
[23]
|
Fujimoto K, Fukagawa K, Sakata T, et al. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats[J]. J Clin Invest, 1993, 91(4):1830-1833. |
[24]
|
Hollander P, Maggs DG, Ruggles JA, et al. Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients[J]. Obes Res, 2004, 12(4):661-668. |
[25]
|
Obici S, Feng Z, Morgan K, et al. Central administration of oleic acid inhibits glucose production and food intake[J]. Diabetes, 2002, 51(2):271-275. |